6 votes

Chronic - For big pharma, the perfect patient is wealthy, permanently ill and a daily pill-popper. Will medicine ever recover?

1 comment

  1. patience_limited
    Link
    I have personal and professional interests in the economics of U.S. healthcare, and this is a decent summary of the state of play for pharmaceutical company drug development vs. other...

    I have personal and professional interests in the economics of U.S. healthcare, and this is a decent summary of the state of play for pharmaceutical company drug development vs. other interventions which are less tied to private markets.

    To some extent, the essay emphasizes market failures in the U.S., but global pharmaceutical industry tends to follow the biggest spending market. Perverse economic incentives in U.S. law have influenced the availability of medicines globally.